WGTN Master of Drug Discovery and Development

What is the WGTN Master of Drug Discovery and Development?

The Master of Drug Discovery and Development is a 180-point, NZQCF Level 9 programme completed over three trimesters. A lower planning amount of INR 54.62 lakh covers the selected tuition basis, compulsory charges, living and the visa fee. For the Master of Drug Discovery and Development, the published route determines the fee basis and application plan.

The current fee basis remains separate from the published 2027 intake. The University’s official Master of Drug Discovery and Development page provides the structure and dates used here. NZQA classifies master’s degrees at Level 9.

How much does the WGTN Master of Drug Discovery and Development cost?

The full-programme plan is NZD 97,497, or about INR 54.62 lakh, using the current international Chemistry catalogue amount whose fee year is not displayed, plus current compulsory levies, one preferred annual insurance premium, the University's lower Wellington estimate scaled to three trimesters, and the current student visa charge.

The total uses the University's lower NZD 26,000 estimate from its NZD 26,000 to NZD 42,900 range for each 52 weeks. Immigration New Zealand's separate maintenance evidence floor is NZD 20,000 yearly. Converted at NZD 1 = INR 56.0236 using New Zealand Inland Revenue's 15 July 2026 mid-month rate. INR amounts are approximate.

The tuition basis preserves its source status. Where the exact international programme fee is missing, the calculation uses the current 2026 subject rate and is not presented as a University-issued whole-programme quote. The 2027 invoice remains unavailable until the University issues it.

The headline total uses the University’s lower Wellington estimate. A family should also test affordability at NZD 42,900 per 52 weeks. The separate NZD 20,000 immigration figure is only the annual visa evidence floor.

The VUW Postgraduate International Scholarship may contribute NZD 10,000 for an eligible new 180-point international entrant. It is not deducted because an award is not guaranteed. Flights, deposits, outward travel and course or project expenses remain extra.

The INR conversion follows Inland Revenue’s published overseas currency rate. It isn’t a 2027 University invoice.

Can an Indian applicant enter the WGTN Master of Drug Discovery and Development?

An Indian applicant needs a Chemistry or relevant life-science degree with a B+ average in relevant courses as the University's stated norm. Victoria University of Wellington does not publish one universal Indian percentage or CGPA conversion, so it assesses the recognised institution, completed qualification, grading scale and programme-specific preparation individually.

Standard postgraduate English is IELTS 6.5 overall with no band below 6.0.

The programme rule controls over the general postgraduate baseline. Where official pages conflict or omit a grade, the applicable threshold remains unresolved until the programme issues a written decision.

Indian English-medium study is not a general automatic waiver. The current central page lists TOEFL, PTE, Duolingo, Cambridge and the limited prior-study routes.

The programme requirements and standard postgraduate English rules control the academic and language assessment. There’s no published universal Indian marks conversion.

Programme-specific checks

1. Exact academic route

   The exact fee year and programme deadline are not displayed on the checked pages, laboratory activity may require travel between kelburn and lower hutt, and this scientific degree does not qualify a graduate for pharmacist registration.

2. Indian marks conversion limit

   Individual assessment uses the complete transcript, grading scale and relevant course detail.

3. This is not pharmacist registration training

   The Pharmacy Council accredited-programme list does not include the MDDD. The degree develops drug-discovery science but does not qualify a graduate to register as a pharmacist in New Zealand.

How and when should an Indian student apply for the WGTN Master of Drug Discovery and Development?

The programme application page does not publish an exact international close. This page uses 1 September 2026 only as a non-official planning date. The actual date remains unpublished. The timetable below leaves room for document checks, an academic decision and the visa.

The controlling date and programme route govern a Puaha submission with certified academic, identity and English evidence. Visa eligibility follows only after every Offer of Place condition is satisfied.

This intake now needs an individual readiness check. Applicants with English results and certified documents ready may still have time. Others should consider the next intake rather than rush an incomplete file.

The allowances are Nbyula planning estimates, not processing times published by Te Herenga Waka: Victoria University of Wellington.

Puaha applications use a personal email and readable certified documents, with certified English translations where required. Programme-specific CV, statement or supporting evidence must also be complete.

The University says postgraduate decisions usually take 3 to 4 weeks. This is a usual processing time, not a decision guarantee, and programme, interview or project review can take longer. Leave the academic offer enough time for conditions, payment and the student visa.

After an offer, meet every condition and prepare visa evidence for tuition, living funds, outward travel, suitable insurance and any required health or character documents.

The programme application page controls the intake date, while Immigration New Zealand makes the student visa decision.

What jobs and work rights can follow the WGTN Master of Drug Discovery and Development?

The curriculum can support pharmaceutical development, veterinary therapeutics, patent assessment, government research and medicines regulation work. Chemist occupation pay is NZD 66,000 to 108,000. This is government occupation context across experience levels, not graduate starting pay. The University publishes no programme placement rate, cohort salary or guaranteed employer pathway.

Chemist pay and named roles at ESR, Ferrier or Medsafe are individual or occupation context. The MDDD does not establish a placement probability, salary, marketable drug, patent, clinical trial or pharmacist registration.

Named student or graduate examples can show how study connects with practice. They remain individual routes and cannot establish a placement probability, starting salary, employer guarantee or professional status for the next cohort.

Current rules may allow eligible students up to 25 work hours weekly and may support a Post Study Work Visa of up to three years after qualifying Level 9 study. The individual visa conditions and rules at application control.

“Apply for this visa if you want to work in New Zealand soon after you have completed your studies here.” Immigration New Zealand

This is conditional permission, not an earnings plan. That doesn’t turn work rights or the post-study visa into a job guarantee.

Who is the WGTN Master of Drug Discovery and Development for?

The final choice still depends on route fit, cost and the stated uncertainties. Written confirmation matters wherever the checked sources leave a route or threshold unresolved. A workable shortlist therefore needs both academic fit and a fully funded study plan.

It is a poor fit for someone relying on guaranteed placement, a published salary outcome, or a route contradicted by the current Calendar or programme page.

The strongest fit comes from matching prior preparation, pathway and intended project. Resolve any route, attendance, progression or professional-status ambiguity in writing rather than relying on a scholarship, paid placement or immediate job.

What does the WGTN Master of Drug Discovery and Development curriculum contain?

The current regulations publish 120 points of drug-discovery coursework and research preparation followed by an applied or laboratory project, with a permission-based thesis substitution. The table includes every named module or formal range in the dossier, together with the project and progression rules that determine completion.

Every published module or formal requirement

• Complete DRGD 401 and one of DRGD 402 or CHEM 421
• Complete DRGD 580 and 60 further approved points from the published BIOL, BMSC, BTEC, CHEM, CLNR, DRGD and MBIO ranges
• Complete either DRGD 561 or DRGD 590
• With programme-director permission, replace DRGD 580 and the 60-point project with DRGD 595
• Follow the selected Chemical Biology, Drug Development or Drug Discovery specialisation requirements where applicable

Availability, prerequisites and programme approval still control the final enrolment plan.

The course list preserves formal codes and range requirements rather than replacing them with invented topic buckets. A valid Calendar option may not run in the intended year.

The 90-point DRGD 595 thesis can replace both 30-point research preparation and the 60-point project, but only with programme-director permission.

The study page links DRGD 561 to Trimester 1 starters and DRGD 590 to Trimester 2 starters, while the Calendar lists them simply as alternatives. The intake-specific project remains unresolved between the published sources.

The official study details and 2026 Calendar control the course list and route rules.

Should an Indian student shortlist the WGTN Master of Drug Discovery and Development?

The decision still depends on entry fit, route certainty, total cost and outcome evidence. Admission itself guarantees no scholarship, placement, salary, professional recognition, work visa or residence outcome. A strong application does not remove those programme-specific limits or the need for a realistic budget.

This programme-specific detail should shape course, attendance or project planning before the offer is accepted.

The programme is unsuitable for applicants expecting a guaranteed placement, named host, salary or professional outcome. The University publishes no programme placement rate. Entry, progression, project allocation, immigration permission and later employment remain separate decisions.

Before deciding, compare complete cost, admission fit, application timing and outcome evidence.

Sources

These sources support the programme, admission, cost, experience and immigration information used on this page.

Sources checked on August 27, 2026. This page plans for the 22 February 2027 intake.